If there are still people who are still skeptical of the new coronavirus, or still don’t believe its seriousness, then a new study may change your mind,media reported. A recent study published in The Lancet quantified the number of people most likely to have the most severe and even deadly symptoms of the new coronavirus without a vaccine.
Researchers from the United States, britain and China have concluded that 1.7 billion people — a little more than 20 percent of the world’s population, or about one in five — are at higher risk of experiencing the most severe symptoms of the virus.
“About one in five people worldwide may have an increased risk of developing severe neo-gneudesis once they become infected, but the risk varies widely by age,” the report’s authors told CNBC. “
In this report, if people have at least one underlying disease, such as diabetes, chronic kidney disease, or cardiovascular disease, their risk increases. These conditions stem from research by public health officials in the United States and Britain, as well as by the World Health Organization.
In North America, about 28 per cent of the population (104 million people) falls into this most dangerous category. They span almost all age groups and have at least one potential condition if they are infected with the virus that may exacerbate the virus’s impact on them. The study also noted that the world’s most at-risk regions are in Europe, where about 31 percent of the population is classified as at increased risk of severe neo-covirus cases.
But this is different from the proportion of the report that puts the proportion of the world’s “high risk” population with the most severe cases of new crown virus. About 349 million of these people, or about 4 percent of the world’s population, may need hospital treatment if they are infected with the virus. To make matters worse, these people may not have any underlying health problems at all. Older age appears to be a factor, and men are at higher risk of disease.
The new insights come as researchers continue to work to develop an effective antiviral vaccine, with some promising new findings that 90 percent of volunteers in a new coronavirus vaccine study were able to develop antibodies to protect them from the virus.